Nonmotor Fluctuations in Parkinson's Disease.

The advanced stage of Parkinson's disease (PD) is characterized by motor complications such as motor fluctuations and dyskinesias induced by long-term levodopa treatment. Recent clinical research provides growing evidence that various nonmotor symptoms such as neuropsychiatric, autonomic, and sensory symptoms (particularly pain) also show fluctuations in patients with motor fluctuations (called nonmotor fluctuations or NMF). However, NMF have not yet been adequately considered in routine care of advanced PD patients and only few therapeutic studies are available. Since the pathophysiology of NMF remains largely unknown, innovative therapeutic concepts are largely missing. The close connection of NMF and motor fluctuations, however, strongly suggests that the strategies used to treat motor complications-namely continuous dopaminergic stimulation-also apply for the therapy of NMF. Future controlled clinical trials specifically addressing NMF are urgently warranted.

[1]  Andrew Evans,et al.  Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single‐dose challenges , 2005, Movement disorders : official journal of the Movement Disorder Society.

[2]  M. Onofrj,et al.  COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson’s disease (PD): relevance for motor and non-motor features , 2008, Neuropsychiatric disease and treatment.

[3]  Paolo Barone,et al.  International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study , 2006, Movement disorders : official journal of the Movement Disorder Society.

[4]  K. Chaudhuri,et al.  The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[5]  B. Ford Pain in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[6]  J. D. Parkes,et al.  "ON-OFF" EFFECTS IN PATIENTS WITH PARKINSON'S DISEASE ON CHRONIC LEVODOPA THERAPY , 1976, The Lancet.

[7]  William W. McDonald,et al.  Depression rating scales in Parkinson's disease: Critique and recommendations , 2007, Movement disorders : official journal of the Movement Disorder Society.

[8]  S. Cheon,et al.  Nonmotor symptoms more closely related to Parkinson's disease: Comparison with normal elderly , 2013, Journal of the Neurological Sciences.

[9]  S. Snider,et al.  Sensory symptoms , 1985, Neurology.

[10]  G. Ebersbach,et al.  Intraindividual Variability of Nonmotor Fluctuations in Advanced Parkinson's Disease. , 2015, Journal of Parkinson's disease.

[11]  T. Müller Tolcapone addition improves Parkinson’s disease associated nonmotor symptoms , 2014, Therapeutic advances in neurological disorders.

[12]  R. M. Stewart,et al.  The sensitivity and specificity of the 9-item Wearing-off Questionnaire. , 2008, Parkinsonism & related disorders.

[13]  F. Carrillo,et al.  Long-term levodopa/carbidopa intestinal gel in advanced Parkinson’s disease , 2014, Journal of Neurology.

[14]  K. Chaudhuri,et al.  Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment , 2009, The Lancet Neurology.

[15]  Jean Régis,et al.  Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[16]  A. Rajput,et al.  Tolcapone improves motor function in parkinsonian patients with the"wearing-off" phenomenon: A double-blind, placebo-controlled, multicenter trial , 1997, Neurology.

[17]  E. Mohr,et al.  Dopamine and memory function in Parkinson's disease , 1989, Movement disorders : official journal of the Movement Disorder Society.

[18]  M. Mark,et al.  Drenching sweats as an off phenomenon in parkinson's disease: Treatment and relation to plasma levodopa profile , 1995, Annals of neurology.

[19]  A M Stiggelbout,et al.  Assessment of cognition in Parkinson’s disease , 2003, Neurology.

[20]  P. James An Essay on the Shaking Palsy , 1817, The Medico-Chirurgical Journal and Review.

[21]  [Micturition disturbances in Parkinson's disease. Clinical and urodynamic evaluation]. , 2002, Neurologia i neurochirurgia polska.

[22]  M. Cosio,et al.  Reversibility of upper airway obstruction after levodopa therapy in Parkinson's disease. , 1989, Chest.

[23]  N. Tuncer,et al.  The Clinical Profile of Nonmotor Fluctuations in Parkinson's Disease Patients , 2002, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[24]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[25]  Angelo Antonini,et al.  Wearing‐off scales in Parkinson's disease: Critique and recommendations , 2011, Movement disorders : official journal of the Movement Disorder Society.

[26]  A. Lang,et al.  The spectrum of levodopa‐related fluctuations in Parkinson's disease , 1993, Neurology.

[27]  M Zappia,et al.  International study on the psychometric attributes of the Non-Motor Symptoms Scale in Parkinson disease , 2009, Neurology.

[28]  H. Reichmann,et al.  Nonmotor fluctuations in Parkinson disease , 2013, Neurology.

[29]  G. Ebersbach,et al.  Assessment of Nonmotor Fluctuations Using a Diary in Advanced Parkinson's disease. , 2016, Journal of Parkinson's disease.

[30]  W. Weiner,et al.  Practice Parameter: Treatment of nonmotor symptoms of Parkinson disease , 2010, Neurology.

[31]  P. Krack,et al.  The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations , 2016, Movement disorders : official journal of the Movement Disorder Society.

[32]  J. Lou Fatigue in Parkinson's disease and potential interventions. , 2015, NeuroRehabilitation.

[33]  T. Anderson,et al.  The MoCA , 2010, Neurology.

[34]  E. Chudler,et al.  The role of the basal ganglia in nociception and pain , 1995, Pain.

[35]  A. Lang,et al.  Development of a Non-Motor Fluctuation Assessment Instrument for Parkinson Disease , 2011, Parkinson's disease.

[36]  P. Stanzione,et al.  Two‐year, randomized, controlled study of safinamide as add‐on to levodopa in mid to late Parkinson's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.

[37]  P Soliveri,et al.  Motor and cognitive performances of parkinsonian patients in the on and off phases of the disease. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[38]  K. Chaudhuri,et al.  Motor and nonmotor complications in Parkinson’s disease: an argument for continuous drug delivery? , 2013, Journal of Neural Transmission.

[39]  J. Cummings,et al.  Parkinson's disease, depression, and the on-off phenomenon. , 1989, Psychosomatics.

[40]  K. Chaudhuri,et al.  Rotigotine transdermal system and evaluation of pain in patients with Parkinson’s disease: a post hoc analysis of the RECOVER study , 2014, BMC Neurology.

[41]  A. Rajput,et al.  Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease , 2013 .

[42]  K. Chaudhuri,et al.  Non-motor symptoms of Parkinson's disease: diagnosis and management , 2006, The Lancet Neurology.

[43]  L. Tremblay,et al.  Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. , 2010, Brain : a journal of neurology.

[44]  A. Albanese,et al.  Early DEtection of wEaring off in Parkinson disease: the DEEP study. , 2014, Parkinsonism & related disorders.

[45]  A. Lees,et al.  On-off fluctuations in Parkinson's disease. A clinical and neuropharmacological study. , 1984, Brain : a journal of neurology.

[46]  L. Defebvre,et al.  Apathy in untreated early‐stage Parkinson disease: Relationship with other non‐motor symptoms , 2014, Movement disorders : official journal of the Movement Disorder Society.

[47]  Mark Stacy,et al.  Identification of motor and nonmotor wearing‐off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment , 2005, Movement disorders : official journal of the Movement Disorder Society.

[48]  T. Anderson,et al.  Rotigotine Effects on Early Morning Motor Function and Sleep in Parkinson's Disease: A Double-Blind, Randomized, pLacebo-Controlled Study (RECOVER) , 2010, Movement disorders : official journal of the Movement Disorder Society.

[49]  H. Reichmann,et al.  Quantitative assessment of non-motor fluctuations in Parkinson’s disease using the Non-Motor Symptoms Scale (NMSS) , 2015, Journal of Neural Transmission.

[50]  J. Sage,et al.  Nonmotor fluctuations in patients with Parkinson's disease , 1996, Neurology.

[51]  M. Stacy,et al.  Development of a Patient Questionnaire to facilitate recognition of motor and non-motor wearing-off in Parkinson’s disease , 2007, Journal of Neural Transmission.

[52]  A. Lang,et al.  Posteroventral medial pallidotomy in advanced Parkinson's disease. , 1997, Advances in neurology.

[53]  A. Lang,et al.  Akathisia in idiopathic Parkinson's disease. , 1987, Neurology.

[54]  S. Factor,et al.  Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.

[55]  A. Mendes,et al.  Abnormal Olfaction in Parkinson's Disease Is Related to Faster Disease Progression , 2015, Behavioural neurology.

[56]  P. Svenningsson,et al.  EuroInf: A Multicenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[57]  J. Nutt,et al.  Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease , 1995, Neurology.

[58]  J. Nutt,et al.  Mood response to levodopa infusion in early Parkinson's disease. , 1998, Neurology.

[59]  E. Dietrichs,et al.  Characterizing motor and non-motor aspects of early-morning off periods in Parkinson's disease: an international multicenter study. , 2014, Parkinsonism & related disorders.

[60]  R. Pahwa,et al.  Subcutaneous apomorphine in patients with advanced Parkinson's disease: A dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose , 2007, Journal of the Neurological Sciences.

[61]  M. T. Pellecchia,et al.  Gender and non motor fluctuations in Parkinson's disease: A prospective study. , 2016, Parkinsonism & related disorders.

[62]  Pablo Martinez-Martin,et al.  Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients , 2007, Movement disorders : official journal of the Movement Disorder Society.

[63]  K. Chaudhuri,et al.  New clinical trials for nonmotor manifestations of Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[64]  C. Marsden,et al.  Mood swings associated with the ‘on—off’ phenomenon in Parkinson's disease , 1987, Psychological Medicine.

[65]  A. Benabid,et al.  Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. , 2003, The New England journal of medicine.

[66]  A. Kishore,et al.  Do nonmotor symptoms in Parkinson's disease differ from normal aging? , 2011, Movement disorders : official journal of the Movement Disorder Society.

[67]  L. Grégoire,et al.  Risk Factors for Peak Dose Dyskinesia in 100 Levodopa-treated Parkinsonian Patients , 1996, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[68]  O Rascol A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group , 2000 .

[69]  J. Friedman,et al.  Rotigotine and specific non-motor symptoms of Parkinson's disease: post hoc analysis of RECOVER. , 2013, Parkinsonism & related disorders.

[70]  C. Marsden,et al.  PAINFUL PARKINSON'S DISEASE , 1986, The Lancet.

[71]  Paolo Barone,et al.  The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study , 2007, Movement disorders : official journal of the Movement Disorder Society.

[72]  A. Zenzola,et al.  Fatigue in Parkinson’s disease , 2003, Neurological Sciences.

[73]  P. Odin,et al.  Continuous dopaminergic stimulation therapy for Parkinson's disease - recent advances. , 2016, Current opinion in neurology.

[74]  D. Bailey,et al.  18F‐dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's disease , 2002, Synapse.

[75]  G. Deuschl,et al.  Neurostimulation for Parkinson's disease with early motor complications. , 2013, The New England journal of medicine.

[76]  W. Poewe,et al.  High‐speed memory scanning in Parkmson's disease: Adverse effects of levodopa , 1991, Annals of neurology.

[77]  M. Ceccaldi,et al.  Nonmotor fluctuations in Parkinson’s disease: Frequent and disabling , 2002, Neurology.

[78]  W. Oertel,et al.  Catechol-O-methyltransferase inhibition with tolcapone reduces the"wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patients , 1997, Neurology.

[79]  L. Seeberger,et al.  A Home Diary to Assess Functional Status in Patients with Parkinson's Disease with Motor Fluctuations and Dyskinesia , 2000, Clinical neuropharmacology.

[80]  P. Rabins,et al.  Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[81]  E. Dietrichs,et al.  Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program. , 2015, Parkinsonism & related disorders.

[82]  R. Cools Dopaminergic modulation of cognitive function-implications for l-DOPA treatment in Parkinson's disease , 2006, Neuroscience & Biobehavioral Reviews.

[83]  K. Kieburtz,et al.  Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study , 2014, The Lancet Neurology.

[84]  Z. Wszolek,et al.  Anorectal function in fluctuating (on‐off) Parkinson's disease: Evaluation by combined anorectal manometry and electromyography , 1995, Movement disorders : official journal of the Movement Disorder Society.

[85]  B. Bergamasco,et al.  Mood changes associated with "end-of-dose deterioration" in Parkinson's disease: a controlled study. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[86]  D. Ye,et al.  Sensory symptoms in Parkinson's disease: Clinical features, pathophysiology, and treatment , 2016, Journal of neuroscience research.

[87]  J. Jankovic,et al.  Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE‐PD study , 2010, Annals of neurology.

[88]  M. Costa,et al.  Anxiety, depression, and quality of life in Parkinson's disease. , 2009, The Journal of neuropsychiatry and clinical neurosciences.

[89]  C. Marsden,et al.  Alterations in cognitive performance and affect-arousal state during fluctuations in motor function in Parkinson's disease. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[90]  J. Groothoff,et al.  The associations between fatigue, apathy, and depression in Parkinson's disease , 2015, Acta neurologica Scandinavica.

[91]  G. Deuschl,et al.  Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease--Clinical practice recommendations. , 2015, Parkinsonism & related disorders.

[92]  Z. Pei,et al.  Nonmotor symptoms are independently associated with impaired health‐related quality of life in Chinese patients with Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[93]  A. Berardelli,et al.  Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. , 2008, Archives of neurology.

[94]  W. Poewe,et al.  The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[95]  J. Lou,et al.  Fatigue in Parkinson's disease: A review , 2007, Movement disorders : official journal of the Movement Disorder Society.

[96]  R. Hauser,et al.  Patient Evaluation of a Home Diary to Assess Duration and Severity of Dyskinesia in Parkinson Disease , 2006, Clinical neuropharmacology.

[97]  S. Calzetti,et al.  Fluctuation of arterial blood pressure during end-of-dose akinesia in Parkinson's disease. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[98]  C. Marsden,et al.  'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. , 1988, Brain : a journal of neurology.

[99]  P. Martínez-Martín,et al.  Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson's disease , 2017, Journal of the Neurological Sciences.

[100]  A. Williams,et al.  Stridor during dystonic phases of Parkinson's disease. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[101]  Anette Schrag,et al.  Quality of life and depression in Parkinson's disease , 2006, Journal of the Neurological Sciences.

[102]  G. Ebersbach,et al.  Tolcapone improves sleep in patients with advanced Parkinson's disease (PD). , 2010, Archives of gerontology and geriatrics.

[103]  Harald Binder,et al.  Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries. , 2014, Parkinsonism & related disorders.

[104]  V. Kostic,et al.  Mild Cognitive Impairment in Early Parkinson's Disease Using the Movement Disorder Society Task Force Criteria: Cross-Sectional Study in Hoehn and Yahr Stage 1 , 2015, Dementia and Geriatric Cognitive Disorders.

[105]  R. Hauser,et al.  Parkinson's disease home diary: Further validation and implications for clinical trials , 2004, Movement disorders : official journal of the Movement Disorder Society.

[106]  J. Friedman,et al.  Fatigue in levodopa-naïve subjects with Parkinson disease , 2008, Neurology.

[107]  C. Wolfson,et al.  Validation of the non-motor symptoms questionnaire (NMS-Quest). , 2012, Parkinsonism & related disorders.

[108]  F. Raudino Non motor off in Parkinson's disease , 2001, Acta neurologica Scandinavica.

[109]  Lucile Brun,et al.  Non-motor fluctuations in Parkinson's disease: Prevalence, characteristics and management in a large cohort of parkinsonian outpatients , 2014, Clinical Neurology and Neurosurgery.

[110]  G. Deuschl,et al.  A randomized trial of deep-brain stimulation for Parkinson's disease. , 2006, The New England journal of medicine.

[111]  C. Adler,et al.  Tolcapone Improves Motor Function and Reduces Levodopa Requirement in Patients with Parkinson's Disease Experiencing Motor Fluctuations , 1997, Neurology.

[112]  W. Jost Autonomic dysfunctions in idiopathic Parkinson's disease , 2003, Journal of Neurology.

[113]  M. Swash,et al.  Anal sphincter dysfunction in Parkinson's disease. , 1989, Archives of neurology.

[114]  Marianna Amboni,et al.  The modern pre-levodopa era of Parkinson’s disease: insights into motor complications from sub-Saharan Africa , 2014, Brain : a journal of neurology.

[115]  R. Helme,et al.  Dyskinetic patients show rebound worsening of affect after an acute L-dopa challenge. , 2012, Parkinsonism & Related Disorders.

[116]  E. Tolosa,et al.  Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial , 2010, The Lancet Neurology.

[117]  J. Jankovic,et al.  Respiratory dyskinesia in Parkinson's disease , 1986, Neurology.

[118]  G. Ebersbach,et al.  Pain intensity on and off levodopa in patients with Parkinson's disease , 2009, Movement Disorders.

[119]  J. Larsen,et al.  Fatigue in patients with Parkinson's disease , 1999, Movement disorders : official journal of the Movement Disorder Society.

[120]  G. Ebersbach,et al.  Timing and Kinetics of Nonmotor Fluctuations in Advanced Parkinson's Disease. , 2017, Journal of Parkinson's disease.

[121]  K. Dujardin,et al.  Impact of Mood and Behavioral Disorders on Quality of Life in Parkinson's disease. , 2016, Journal of Parkinson's disease.

[122]  Paul Krack,et al.  Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil. , 2013, Brain : a journal of neurology.

[123]  P. Martínez-Martín Nonmotor symptoms and health‐related quality of life in early Parkinson's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.

[124]  O. Rascol,et al.  King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation , 2015, Movement disorders : official journal of the Movement Disorder Society.

[125]  Pasquale Calabrese,et al.  Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument , 2008 .

[126]  Edo Richard,et al.  Apathy in Parkinson's disease: A systematic review and meta‐analysis , 2015, Movement disorders : official journal of the Movement Disorder Society.

[127]  K. Safranow,et al.  Ophthalmological Features of Parkinson Disease , 2014, Medical science monitor : international medical journal of experimental and clinical research.

[128]  Angelo Antonini,et al.  The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[129]  Pablo Martinez-Martin,et al.  The importance of non-motor disturbances to quality of life in Parkinson's disease , 2011, Journal of the Neurological Sciences.

[130]  R. Pfeiffer Autonomic dysfunction in Parkinson's disease , 2012, Expert review of neurotherapeutics.

[131]  A. Nieoullon Dopamine and the regulation of cognition and attention , 2002, Progress in Neurobiology.

[132]  R. Duvoisin,et al.  Mood changes and “on‐off” phenomena in Parkinson's disease , 1990, Movement disorders : official journal of the Movement Disorder Society.

[133]  Gabriele Schackert,et al.  Immediate effects of deep brain stimulation of the subthalamic nucleus on nonmotor symptoms in Parkinson's disease. , 2012, Parkinsonism & related disorders.

[134]  D. Brooks,et al.  A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. , 2000, The New England journal of medicine.

[135]  S. Nogawa,et al.  Clinical features and varieties of non-motor fluctuations in Parkinson's disease: a Japanese multicenter study. , 2013, Parkinsonism & related disorders.